Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

Sandoz launches generic version of anti-cancer drug in US

Sandoz Inc., the generic pharmaceutical division of Novartis, has launched the generic version of cyclophosphamide injection, USP, an anti-cancer drug in the US. Sandoz is launching cyclophosphamide injection, USP, through collaboration with Jiangsu ... Individual.com, 3 days ago

2 images for "sandoz inc"

Talk Radio News Service, 1 month ago
Reuters UK, 1 month ago

Sandoz receives marketing authorizations for asthma inhaler in Baltics

Sandoz Inc. has received marketing authorizations from the pharmaceutical regulatory authorities in Estonia, Latvia and Lithuania for AirFluSal Forspiro, a new inhaler for patients with asthma and/or chronic obstructive pulmonary disease, or COPD.
 Individual.com4 days ago
Securities Technology Monitor

Apricus announces launch of erectile dysfunction drug in Belgium by Sandoz

Apricus Biosciences, Inc., a biopharmaceutical company, has announced the launch of Vytaros, for treatment of erectile dysfunction, in Belgium by the Sandoz Division of the Novartis Group of Companies. Apricus' novel topical on-demand treatment for ...
 Individual.com1 week ago Anacor Pharmaceuticals to Present at the 2014 Credit Suisse Healthcare Conference  BioSpace2 weeks ago Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results  Benzinga.com2 weeks ago Anacor Pharmaceuticals : to Present at the 2014 Credit Suisse Healthcare Conference  4 Traders2 weeks ago
[x]  
Securities Technology Monitor

Medigene's licensee inks promotion pact to expand Veregen product sales in US

Medigene AG announces that its US licensee, Fougera Pharmaceuticals Inc, a Sandoz company, has signed a promotion agreement with Women's Choice Pharmaceuticals LLC (WCP), a specialty pharmaceutical company based in Gilbert, Arizona, for Veregen ...
 PharmaBiz2 weeks ago MEDIGENE : Licensee enters promotion agreement to expand Veregen® product sales in the United States  4 Traders3 weeks ago Medigene's Licensee enters promotion agreement to expand Veregen® product sales in the United States  Yahoo! UK and Ireland3 weeks ago MEDIGENE' : Licensee enters promotion agreement to expand Veregen® product sales in the United States  4 Traders3 weeks ago
[x]  

Amgen, Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst

October 30, 2014 By Riley McDermid , BioSpace.com Breaking News Sr. Editor The battle over biosimilars is just beginning and the skirmish between biotechs Amgen ( AMGN ) and Sandoz is creating some fascinating legal problems, said ...
 BioSpace3 weeks ago Amgen/Sandoz Disputes Will Clarify BPCIA (Biologics Price Competition and Innovation Act) Issues  National Law Review1 week ago Sandoz and Celltrion Decline the Invitation to Dance: Biosimilars Challenge the Applicability of the BPCIA's Exchange Provisions Before Bringing Suit  JD Supra1 week ago

Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters

TRENTON, N.J., Nov. 6 -- The New Jersey Economic Development Authority issued the following news release: Showcasing New Jersey's continued ability to retain life-science companies, Lt. Governor Kim Guadagno today joined executives from Sandoz, ...
 Pharmaceutical & Medical Packaging News1 week ago Novartis : Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters  4 Traders2 weeks ago

Teva Pharmaceuticals USA, Inc v Sandoz, Inc

the Supreme Court heard oral arguments in , regarding the proper standard of review for patent claim constructions. Although de novo review of district court claim constructions has been the US Court of Appeals for the Federal Circuit's modus ...
 Intellectual Property Magazine1 week ago Oral Argument In Teva Pharmaceuticals: Supreme Court To Decide Federal Circuit's Standard Of Review Of District Court Claim Construction Rulings  JD Supra3 weeks ago

United Therapeutics Corp. v. Sandoz, Inc.

Case Name: , Civ. Nos. 12-cv-01617, 13-cv-316, 2014 U.S. Dist. LEXIS 121573 (D.N.J. Aug. 29, 2014) (Sheridan, J.) Drug Product and Patent(s)-in-Suit: Remodulin® (treprostinil sodium); U.S. Patents Nos. 6,576,117 (the 117 patent) and 7,999,007 ...
 JD Supra1 month ago

Harvard Bioscience elects new board member

Harvard Bioscience, Inc., a manufacturer of scientific instruments and apparatus, has elected Bertrand Loy to its board of directors. Mr Loy is President and CEO of Entegris Inc., a provider of yield-enhancing materials and solutions used in ...
 Individual.com1 week ago
Freshnews.com

Cubist Pharmaceuticals names EVP and COO

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has promoted Patrick Vink, current senior vice president and general manager of the company's international business, to the role of executive vice president, or EVP, and COO, effective ...
 Individual.com1 week ago Cubist Names Dr. Patrick Vink Chief Operating Officer  CNBC2 weeks ago Cubist Pharmaceuticals : Names Dr. Patrick Vink Chief Operating Officer  4 Traders2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less